IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes

Diabetes Research and Clinical Practice

Volumn 117, Issue , 2016, Pages 48-54

  da Rocha Fernandes, Joao ^a   Ogurtsova, Katherine ^a   Linnenkamp, Ute ^a   Guariguata, Leonor ^a   Seuring, Till ^a   Zhang, Ping ^b   Cavan, David ^a   Makaroff, Lydia E ^a  

^a International Diabetes Federation   (Belgium)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cost; Diabetes mellitus; Economic burden; Expenditures; Health economics; IDF

Indexed keywords

AFRICA; ARTICLE; CARIBBEAN; DIABETES MELLITUS; EUROPE; HEALTH CARE COST; HUMAN; MIDDLE EAST; NORTH AFRICA; NORTH AMERICA; PREVALENCE; SOUTHEAST ASIA; ADULT; AGED; DISEASE MANAGEMENT; ECONOMICS; FEMALE; GLOBAL HEALTH; MALE; MIDDLE AGED; PUBLIC HEALTH; YOUNG ADULT;

ADULT; AGED; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; GLOBAL HEALTH; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MIDDLE AGED; PUBLIC HEALTH; YOUNG ADULT;

EID: 84968877365     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2016.04.016     Document Type: Article

References (26)

1. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103(2):137-149.
2. Beagley J., Guariguata L., Weil C., Motala A.A. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract 2014, 103:150-160.
3. Zhang P., Zhang X., Brown J., Vistisen D., Sicree R., Shaw J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301. 10.1016/j.diabres.2010.01.026.
4. Guariguata L., Whiting D., Weil C., Unwin N. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes Res Clin Pract 2011, 94:322-332. 10.1016/j.diabres.2011.10.040.
5. United Nations World urbanization prospects, the 2014 revision 2014, United Nations, Geneva, Switzerland.
6. World Health Organization WDI World Health Organization national health account database 2014.
7. Organisation for Economic Co-operation and Development World Health Organization, Statistical Office of the European Communities, OECD iLibrary. Inter-country indexes of price and volume. Syst. Health Acc. 2011 2011, OECD, Eurostat, World Health Organization, Paris, Luxembourg, Geneva, p. 314-5.
8. World Health Organization Projections of mortality and burden of disease to 2030 2006.
9. Köster I., von Ferber L., Ihle P., Schubert I., Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 2006, 49:1498-1504. 10.1007/s00125-006-0277-5.
10. American Diabetes Association Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013, 36:1033-1046. 10.2337/dc12-2625.
11. Yang W., Zhao W., Xiao J., Li R., Zhang P., Kissimova-Skarbek K., et al. Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One 2012, 7:e39513. 10.1371/journal.pone.0039513.
12. Huber C.A., Schwenkglenks M., Rapold R., Reich O. Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011. BMC Endocr Disord 2014, 14:44. 10.1186/1472-6823-14-44.
13. Kissimova-Skarbek K., Pach D., Płaczkiewicz E., Szurkowska M., Szybiński Z. Evaluation of the burden of diabetes in Poland. Pol Arch Med Wewn 2001, 106:867-873.
14. Chatterjee S., Riewpaiboon A., Piyauthakit P., Riewpaiboon W., Boupaijit K., Panpuwong N., et al. Cost of diabetes and its complications in Thailand: a complete picture of economic burden. Health Soc Care Community 2011, 19:289-298. 10.1111/j.1365-2524.2010.00981.x.
15. International Diabetes Federation IDF regions 2015.
16. The World Bank Country and lending groups 2015.
17. World Health Organization Per capita government expenditure on health at average exchange rate (US$) 2012.
18. World Health Organization Per capita total expenditure on health (PPP int. $) 2012.
19. Zhuo X., Zhang P., Hoerger T.J. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 2013, 45:253-261. 10.1016/j.amepre.2013.04.017.
20. Javanbakht M., Baradaran H.R., Mashayekhi A., Haghdoost A.A., Khamseh M.E., Kharazmi E., et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS One 2011, 6:e26864. 10.1371/journal.pone.0026864.
21. González J.C., Walker J.H., Einarson T.R. Cost-of-illness study of type 2 diabetes mellitus in Colombia. Rev Panam Salud Pública 2009, 26:55-63. Pan Am J Public Health.
22. Kirigia J.M., Sambo H.B., Sambo L.G., Barry S.P. Economic burden of diabetes mellitus in the WHO African region. BMC Int Health Hum Rights 2009, 9:6. 10.1186/1472-698X-9-6.
23. DPP Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403. 10.1056/NEJMoa012512.
24. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371:1783-1789. 10.1016/S0140-6736(08)60766-7.
25. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A.D., Vijay V., et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49:289-297. 10.1007/s00125-005-0097-z.
26. Li R., Zhang P., Barker L.E., Chowdhury F.M., Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care 2010, 33:1872-1894. 10.2337/dc10-0843.